These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 4783575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. On the mechanism of midtrimester abortions induced by prostaglandin "impact".
    Saldana L, Schulman H, Yang WH.
    Prostaglandins; 1973 Jun; 3(6):847-58. PubMed ID: 4729604
    [Abstract] [Full Text] [Related]

  • 3. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies.
    Csapo AI, Pulkkinen MO, Ruttner B, Sauvage JP, Wiest WG.
    Am J Obstet Gynecol; 1972 Apr 15; 112(8):1061-7. PubMed ID: 5017636
    [Abstract] [Full Text] [Related]

  • 4. Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis.
    Csapo AI, Henzl MR, Kaihola HL, Kivikoski A, Pulkkinen MO.
    Prostaglandins; 1974 Jul 10; 7(1):39-47. PubMed ID: 4605187
    [Abstract] [Full Text] [Related]

  • 5. Massive initial prostaglandin impact in postconceptional therapy.
    Csapo AI, Kivikoski A, Wiest WG.
    Prostaglandins; 1972 Aug 10; 2(2):125-34. PubMed ID: 4653230
    [Abstract] [Full Text] [Related]

  • 6. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence.
    Csapo AI, Pulkkinen M.
    Obstet Gynecol Surv; 1978 Feb 10; 33(2):69-81. PubMed ID: 341008
    [No Abstract] [Full Text] [Related]

  • 7. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH, Wilson KH.
    Am J Obstet Gynecol; 1974 Sep 15; 120(2):273-80. PubMed ID: 4412615
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin-oxytocin enhancement.
    Seppälä M, Vara P.
    Br Med J; 1972 Mar 18; 1(5802):747. PubMed ID: 5015335
    [Abstract] [Full Text] [Related]

  • 9. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L, Caldwell BV, Brock WA, Anderson GG, Hobbins JC.
    J Clin Endocrinol Metab; 1972 Mar 18; 34(3):531-6. PubMed ID: 5011257
    [Abstract] [Full Text] [Related]

  • 10. Plasma progesterone and oestradiol-17beta changes during abortion induced by prostaglandin F2alpha.
    Tyack AJ, Lambadarios C, Parsons RJ, Stewart CR, Cooke ID.
    J Obstet Gynaecol Br Commonw; 1974 Jan 18; 81(1):52-6. PubMed ID: 4818317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Uterine contractility during pregnancy and the effect of abortifacient drugs.
    Bygdeman M, Swahn ML.
    Baillieres Clin Obstet Gynaecol; 1990 Jun 18; 4(2):249-61. PubMed ID: 2225598
    [Abstract] [Full Text] [Related]

  • 13. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML, Bygdeman M.
    Br J Obstet Gynaecol; 1988 Feb 18; 95(2):126-34. PubMed ID: 3349002
    [Abstract] [Full Text] [Related]

  • 14. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S, Zador G, Nygren KG, Wide L.
    Gynecol Obstet Invest; 1981 Feb 18; 12(4):203-10. PubMed ID: 7250783
    [Abstract] [Full Text] [Related]

  • 15. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
    Lange AP, Secher NJ, Pedersen GT.
    Prostaglandins; 1974 Apr 25; 6(2):149-57. PubMed ID: 4847514
    [Abstract] [Full Text] [Related]

  • 16. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
    Selinger M, Mackenzie IZ, Gillmer MD, Phipps SL, Ferguson J.
    Br J Obstet Gynaecol; 1987 Dec 25; 94(12):1218-22. PubMed ID: 3322376
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The efficacy and acceptability of the "prostaglandin impact" in inducing complete abortion during the second week after the missed menstrual period.
    Csapo AI, Mocsary P, Nagy T, Kaihola HL.
    Prostaglandins; 1973 Feb 25; 3(2):125-39. PubMed ID: 4729565
    [Abstract] [Full Text] [Related]

  • 19. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP, Laumas V, Agarwal N, Zoremthangi, Hingorani V, Laumas KR.
    Prostaglandins; 1977 Feb 25; 13(2):363-73. PubMed ID: 847240
    [Abstract] [Full Text] [Related]

  • 20. The prospects of PGs in postconceptional therapy.
    Csapo AI.
    Prostaglandins; 1973 Mar 25; 3(3):245-89. PubMed ID: 4580931
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.